Alternatives to standard BEP x 3 in good-prognosis germ cell tumors--you bet your life.

Suppr

超能文献

作者信息

Nichols Craig, Kollmannsberger Christian

出版信息

J Natl Cancer Inst. 2010 Aug 18;102(16):1214-5. doi: 10.1093/jnci/djq266. Epub 2010 Jul 14.

DOI:10.1093/jnci/djq266

PMID:20631340

Abstract

摘要

相似文献

Alternatives to standard BEP x 3 in good-prognosis germ cell tumors--you bet your life.

J Natl Cancer Inst. 2010 Aug 18;102(16):1214-5. doi: 10.1093/jnci/djq266. Epub 2010 Jul 14.

Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.

J Natl Cancer Inst. 2010 Aug 18;102(16):1253-62. doi: 10.1093/jnci/djq245. Epub 2010 Jul 14.

Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.

Hinyokika Kiyo. 2007 Dec;53(12):851-6.

Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.

Cancer Treat Rep. 1987 Jun;71(6):655-6.

Chemotherapy for good-risk germ cell tumors: current concepts and controversies.

Urol Clin North Am. 2007 May;34(2):171-7; abstract viii-ix. doi: 10.1016/j.ucl.2007.03.001.

Management of good risk germ-cell tumours.

BJU Int. 2009 Nov;104(9 Pt B):1387-91. doi: 10.1111/j.1464-410X.2009.08864.x.

Poor prognosis germ cell tumors of the testes: improved results with high dose regimens.

Prog Clin Biol Res. 1988;269:419-27.

High-dose chemotherapy in nonseminomatous germ cell cancer.

BJU Int. 2009 Nov;104(9 Pt B):1398-403. doi: 10.1111/j.1464-410X.2009.08866.x.

Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.

J Urol. 1997 Mar;157(3):855-8; discussion 858-9.

Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council.

J Clin Oncol. 2001 Mar 15;19(6):1629-40. doi: 10.1200/JCO.2001.19.6.1629.

引用本文的文献

Treatment de-escalation for stage II seminoma.

Nat Rev Urol. 2023 Aug;20(8):502-512. doi: 10.1038/s41585-023-00727-0. Epub 2023 Mar 7.

Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors.

Oncologist. 2021 Jun;26(6):483-491. doi: 10.1002/onco.13719. Epub 2021 Mar 12.

Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.

Oncologist. 2020 Oct;25(10):e1509-e1515. doi: 10.1634/theoncologist.2020-0420. Epub 2020 Sep 18.

Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment.

Transl Androl Urol. 2020 Jan;9(Suppl 1):S56-S65. doi: 10.21037/tau.2019.09.11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验